Accolate (zafirlukast) MIGHT lead to liver dysfunction
August 1997
Zeneca is now cautioning that their new asthma drug Accolate (zafirlukast) MIGHT lead to liver dysfunction.
The other leukotriene inhibitor, Zyflo (zileuton) has strong warnings about liver toxicity. Patients starting Zyflo should get at least seven liver function tests in the first year.
With Accolate you only need to suggest liver tests if patients develop symptoms...nausea, jaundice, or abdominal pain.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote